Mechanistically, aspirin can directly acetylate fibrinogen-like protein 1 and promote its degradation, enhancing immunotherapeutic efficacy and inducing hepatocellular carcinoma regression [51]. The gene discussed is FGL1; the disease is hepatocellular carcinoma.